Trissel L A, Martinez J F, Xu Q A
Division of Pharmacy, University of Texas, M. D. Anderson Cancer Center, Houston 77030, USA.
Am J Health Syst Pharm. 1995 Apr 1;52(7):710-5. doi: 10.1093/ajhp/52.7.710.
The physical compatibility of fluorouracil mixed with leucovorin calcium or levoleucovorin calcium, undiluted and modestly diluted with 5% dextrose injection, was evaluated. Fluorouracil 50 mg/mL was combined in duplicate with leucovorin or levoleucovorin 20 mg/mL (as the calcium salt) in 250-mL polyvinyl chloride (PVC) portable-pump reservoirs in six volume ratios, either undiluted or diluted with 5% dextrose injection (to a final volume 25% greater than the drug volume). Duplicate reservoirs of each combination were stored for seven days at 4, 23, or 32 degrees C. Samples were evaluated visually with a high-intensity monodirectional light beam to observe development of particulates. Turbidimetry and light-obscuration particle counting and sizing also were used to evaluate compatibility. Small amounts of tiny crystalline particles developed in most of the combinations, usually by four days. In some cases, the particles could be seen in normal diffuse room light. Particle content was greater with higher leucovorin concentrations and over longer storage periods. Storage temperature did not play a consistent role in particle development. Fluorouracil and leucovorin calcium or levoleucovorin calcium were not compatible when stored in PVC reservoirs at 4, 23, or 32 degrees C.
评估了氟尿嘧啶与亚叶酸钙或左亚叶酸钙混合后的物理相容性,混合液未稀释以及用5%葡萄糖注射液适度稀释。将50mg/mL的氟尿嘧啶与20mg/mL(钙盐形式)的亚叶酸或左亚叶酸以六种体积比一式两份混合于250mL聚氯乙烯(PVC)便携式泵储液器中,混合液要么未稀释,要么用5%葡萄糖注射液稀释(最终体积比药物体积大25%)。每种组合的一式两份储液器在4℃、23℃或32℃下储存7天。用高强度单向光束对样品进行目视评估,以观察颗粒的形成情况。还使用比浊法以及光阻法颗粒计数和粒度分析来评估相容性。大多数组合中通常在四天内会出现少量微小结晶颗粒。在某些情况下,在正常的室内漫射光下就能看到这些颗粒。亚叶酸浓度越高且储存时间越长,颗粒含量越高。储存温度在颗粒形成过程中并非始终发挥一致作用。当在4℃、23℃或32℃下储存在PVC储液器中时,氟尿嘧啶与亚叶酸钙或左亚叶酸钙不相容。